Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice

Biochemical and Biophysical Research Communications

Volumn 381, Issue 4, 2009, Pages 528-532

  Fu, Yuanhui ^a,b   He, Jinsheng ^b,c   Zheng, Xianxian ^c   Wu, Qiang ^c   Zhang, Mei ^c   Wang, Xiaobo ^c   Wang, Yan ^c   Xie, Can ^c   Tang, Qian ^c   Wei, Wei ^c   Wang, Min ^a   Song, Jingdong ^a   Qu, Jianguo ^a   Zhang, Ying ^b   Wang, Xin ^b   Hong, Tao ^a,b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b BEIJING JIAOTONG UNIVERSITY   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Human respiratory syncytial virus; Protective immunity; Replication deficient adenoviral vector

Indexed keywords

ADENOVIRUS VECTOR; GLYCOPROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS FUSION PROTEIN;

ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EMBRYO; EXPERIMENTAL MODEL; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TH1 CELL; TH2 CELL; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION;

ADENOVIRIDAE; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODY FORMATION; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; GENETIC VECTORS; HUMANS; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; VACCINATION; VIRAL FUSION PROTEINS; VIRUS REPLICATION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; MURINAE; MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 62949177862     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.02.075     Document Type: Article

References (35)

1. Collins P.L., and Crowe Jr. J.E. Respiratory syncytial virus and metapneumovirus. In: Howley P.M., Knipe D.M., Griffin D.E., Lamb R.A., Martin M.A., Roizman B., and Straus S.E. (Eds). Fields Virology (2007), Lippincott Williams & Wilkins, Philadelphia 1601-1646
2. Brandenburg A.H., Neijens H.J., and Osterhaus A.D. Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development. Vaccine 19 (2001) 2769-2782
3. Girard M.P., Cherian T., Pervikov Y., and Kieny M.P. A review of vaccine research and development: human acute respiratory infections. Vaccine 23 (2005) 5708-5724
4. Fleming D.M., and Elliot A.J. Respiratory syncytial virus: a sleeping giant?. Eur. Respir. J. 30 (2007) 1029-1031
5. Gao W., Soloff A.C., Lu X., Montecalvo A., Nguyen D.C., Matsuoka Y., Robbins P.D., Swayne D.E., Donis R.O., Katz J.M., Barratt-Boyes S.M., and Gambotto A. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J. Virol. 80 (2006) 1959-1964
6. Casimiro D.R., Chen L., Fu T.M., Evans R.K., Caulfield M.J., Davies M.E., Tang A., Chen M., Huang L., Harris V., Freed D.C., Wilson K.A., Dubey S., Zhu D.M., Nawrocki D., Mach H., Troutman R., Isopi L., Williams D., Hurni W., Xu Z., Smith J.G., Wang S., Liu X., Guan L., Long R., Trigona W., Heidecker G.J., Perry H.C., Persaud N., Toner T.J., Su Q., Liang X., Youil R., Chastain M., Bett A.J., Volkin D.B., Emini E.A., and Shiver J.W. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 77 (2003) 6305-6313
7. Yu J.R., Kim S., Lee J.B., and Chang J. Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection. J. Virol. 82 (2008) 2350-2357
8. Alwan W.H., Record F.M., and Openshaw P.J. CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells. Clin. Exp. Immunol. 88 (1992) 527-536
9. Srikiatkhachorn A., and Braciale T.J. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186 (1997) 421-432
10. Heidema J., de Bree G.J., De Graaff P.M., van Maren W.W., Hoogerhout P., Out T.A., Kimpen J.L., and van Bleek G.M. Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes. J. Gen. Virol. 85 (2004) 2365-2374
11. Bukreyev A., Yang L., Fricke J., Cheng L., Ward J.M., Murphy B.R., and Collins P.L. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes. J. Virol. 82 (2008) 12191-12204
12. Moore E.C., Barber J., and Tripp R.A. Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15). J. Virol. 5 (2008) 116
13. Collins P.L., and Crowe Jr. J.E. Respiratory Syncytial Virus and Metapneumovirus (2007), Lippincott Williams & Wilkins a Wolters Kluwer Business,, Philadelphia
14. Anderson L.J., Hierholzer J.C., Tsou C., Hendry R.M., Fernie B.F., Stone Y., and McIntosh K. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J. Infect. Dis. 151 (1985) 626-633
15. Eckardt-Michel J., Lorek M., Baxmann D., Grunwald T., Keil G.M., and Zimmer G. The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis. J. Virol. 82 (2008) 3236-3249
16. Ng P., and Graham F.L. Construction of First-Generation Adenoviral Vectors (2002), Humana Press Inc., Totowa, NJ
17. Xie C., He J.S., Zhang M., Xue S.L., Wu Q., Ding X.D., Song W., Yuan Y., Li D.L., Zheng X.X., Lu Y.Y., and Shang Z. Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by attenuated Salmonella typhimurium. Hum. Gene Ther. 18 (2007) 746-752
18. Prince G.A., Curtis S.J., Yim K.C., and Porter D.D. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine. J. Gen. Virol. 82 (2001) 2881-2888
19. Collins P.L., and Murphy B.R. New generation live vaccines against human respiratory syncytial virus designed by reverse genetics. Proc. Am. Thorac. Soc. 2 (2005) 166-173
20. Xiang Z.Q., Yang Y., Wilson J.M., and Ertl H.C. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219 (1996) 220-227
21. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., and Finberg R.W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275 (1997) 1320-1323
22. Ali M., Lemoine N.R., and Ring C.J. The use of DNA viruses as vectors for gene therapy. Gene Ther. 1 (1994) 367-384
23. Jooss K., Yang Y., Fisher K.J., and Wilson J.M. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72 (1998) 4212-4223
24. Rea D., Schagen F.H., Hoeben R.C., Mehtali M., Havenga M.J., Toes R.E., Melief C.J., and Offringa R. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J. Virol. 73 (1999) 10245-10253
25. Molinier-Frenkel V., Lengagne R., Gaden F., Hong S.S., Choppin J., Gahery-Segard H., Boulanger P., and Guillet J.G. Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J. Virol. 76 (2002) 127-135
26. Molinier-Frenkel V., Prevost-Blondel A., Hong S.S., Lengagne R., Boudaly S., Magnusson M.K., Boulanger P., and Guillet J.G. The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain. J. Biol. Chem. 278 (2003) 37175-37182
27. Philpott N.J., Nociari M., Elkon K.B., and Falck-Pedersen E. Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway. Proc. Natl. Acad. Sci. USA 101 (2004) 6200-6205
28. Yamaguchi T., Kawabata K., Koizumi N., Sakurai F., Nakashima K., Sakurai H., Sasaki T., Okada N., Yamanishi K., and Mizuguchi H. Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. Hum. Gene Ther. 18 (2007) 753-762
29. Sarukhan A., Camugli S., Gjata B., von Boehmer H., Danos O., and Jooss K. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J. Virol. 75 (2001) 269-277
30. A.K. Abbas, A.H. Lichtman, S. Pillai, Activation of T lymphocytes, in: A.K. Abbas, A.H. Lichtman, S. Pillai (EDs.), Cellular Molecular Immunology, Saunders Elsevier, Philadelphia, PA, 2007, pp. 189-214.
31. Elliott M.B., Chen T., Terio N.B., Chong S.Y., Abdullah R., Luckay A., Egan M.A., Boutilier L.A., Melville K., Lerch R.A., Long D., Eldridge J.H., Parks C.L., Udem S.A., and Hancock G.E. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques. Vaccine 25 (2007) 7132-7144
32. Mok H., Lee S., Utley T.J., Shepherd B.E., Polosukhin V.V., Collier M.L., Davis N.L., Johnston R.E., and Crowe Jr. J.E. Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats. J. Virol. 81 (2007) 13710-13722
33. Varga S.M. Fixing a failed vaccine. Nat. Med. 15 (2009) 21-22
34. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., and Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1 (2000) 398-401
35. Ternette N., Tippler B., Uberla K., and Grunwald T. Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus. Vaccine 25 (2007) 7271-7279